UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019489
Receipt number R000022536
Scientific Title Oral immunotherapy for children with egg allergy: a randomized controlled trial
Date of disclosure of the study information 2015/12/01
Last modified on 2023/05/01 18:52:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Oral immunotherapy for children with egg allergy: a randomized controlled trial

Acronym

Oral immunotherapy for egg allergy

Scientific Title

Oral immunotherapy for children with egg allergy: a randomized controlled trial

Scientific Title:Acronym

Oral immunotherapy for egg allergy

Region

Japan


Condition

Condition

Food allergy (egg)

Classification by specialty

Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of oral immunotherapy for egg allergy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The proportion of patients with negative results of egg oral food challenge

Key secondary outcomes

(1) Change in threshold dose of oral food challenge before and after oral immunotherapy (at registration and 12 months of maintenance phase) in each subject
(2)The frequency of allergic symptoms and rescue drug use
(3)Change in allergen-specific immunoglobulin
(4)Change in QOL by questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Oral immunotherapy with egg

Interventions/Control_2

Oral immunotherapy with egg after 6 months of elimination diet

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

Egg allergy patients with threshold of 2 g or more, and 10 g or less in oral food challenge

Key exclusion criteria

(1)History of heart, liver and/or renal diseases
(2)Poorly controlled bronchial asthma and/or atopic dermatitis
(3)Patients during oral immunotherapy for other food allergen
(4)Patients whom the doctor assess ineligible

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mayumi Sugimoto

Organization

Tokushima University Hospital

Division name

Department of Pediatrics

Zip code


Address

3-18-15, Kuramoto-cho, Tokushima, Japan

TEL

088-633-7135

Email

sugimoto.mayumi@tokushima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mayumi Sugimoto

Organization

Tokushima University Hospital

Division name

Department of Pediatrics

Zip code


Address

3-18-15, Kuramoto-cho, Tokushima, Japan

TEL

088-633-7135

Homepage URL


Email

sugimoto.mayumi@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学病院(徳島県)


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB

2015 Year 10 Month 07 Day

Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date

2017 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 25 Day

Last modified on

2023 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022536


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name